Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -205,349 | -159,155 | -608,658 | 111,820 | -115,376 |
| Depreciation Amortization | 11,402 | 11,100 | 11,939 | 9,515 | 6,995 |
| Accounts receivable | 61,556 | -19,139 | 12,461 | -79,527 | 2,987 |
| Accounts payable and accrued liabilities | -47,921 | -22,224 | -107,444 | 88,534 | 14,787 |
| Other Working Capital | 7,807 | -54,192 | -210,123 | 14,309 | 19,973 |
| Other Operating Activity | -147,679 | -142,751 | 332,227 | -104,363 | -19,121 |
| Operating Cash Flow | $-320,184 | $-386,361 | $-569,598 | $40,289 | $-89,755 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54 | 224 | 3,062,431 | -326,261 | 27,837 |
| PPE Investments | -378 | -2,036 | -4,508 | -5,089 | -3,453 |
| Net Acquisitions | N/A | N/A | -1,427,540 | 2,830 | N/A |
| Purchase Of Investment | -3,410,508 | -1,985,885 | N/A | -1,427,567 | -292,843 |
| Sale Of Investment | 3,410,586 | 2,360,750 | 1,475,269 | 801,178 | 356,966 |
| Purchase Sale Intangibles | -2,731 | -14,009 | -26,438 | -51,268 | -630 |
| Other Investing Activity | 16,994 | -9,557 | -4,088,820 | -49,884 | -529 |
| Investing Cash Flow | $16,640 | $363,496 | $-983,168 | $-1,004,793 | $87,979 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 25,049 | -942 | 949,145 | 4,160 |
| Debt Repayment | -43,569 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 111,148 | N/A | 100,244 | 92,068 | N/A |
| Other Financing Activity | -21,041 | 303,061 | 1,465,849 | -4,933 | -3,765 |
| Financing Cash Flow | $46,537 | $328,110 | $1,565,151 | $1,036,279 | $396 |
| Exchange Rate Effect | -6,913 | -11,182 | 3,532 | 3,881 | 98 |
| Beginning Cash Position | 435,464 | 129,854 | 129,898 | 50,620 | 50,915 |
| End Cash Position | 171,544 | 423,917 | 145,815 | 125,419 | 49,632 |
| Net Cash Flow | $-263,920 | $294,063 | $15,917 | $74,799 | $-1,283 |
| Free Cash Flow | |||||
| Operating Cash Flow | -320,184 | -386,361 | -569,598 | 40,289 | -89,755 |
| Capital Expenditure | -378 | -2,036 | -4,508 | -5,089 | -3,476 |
| Free Cash Flow | -320,563 | -388,397 | -574,106 | 35,199 | -93,231 |